sample size for clini­cal endpoint BE study of Brinzol­amide 1% ophthal­mic [Design Issues]

posted by kishpokuri – India, 2015-11-24 15:18 (3511 d 04:00 ago) – Posting: # 15665
Views: 7,422

Hi all,
Can anyone suggest the appropriate sample size for a clinical endpoint bioequivalence study of Brinzolamide 1% ophthalmic suspension in chronic open angle glaucoma patients.
OGD guidelines has not mentioned regarding this.:confused:
Thank you,
Regards,
Dr. Kishan PV


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,685 registered users;
60 visitors (0 registered, 60 guests [including 8 identified bots]).
Forum time: 20:19 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5